Spotlight
Clinical
Events
CME
Partners
Subscribe
- COVID-19
- Biosimilars
- Cataract Therapeutics
- DME
- Gene Therapy
- Workplace
- Ptosis
- Optic Relief
- Imaging
- Geographic Atrophy
- AMD
- Presbyopia
- Ocular Surface Disease
- Practice Management
- Pediatrics
- Surgery
- Therapeutics
- Optometry
- Retina
- Cataract
- Pharmacy
- IOL
- Dry Eye
- Understanding Antibiotic Resistance
- Refractive
- Cornea
- Glaucoma
- OCT
- Ocular Allergy
- Clinical Diagnosis
- Technology
Luxottica eyes Cole National in deal for $401 million
Cleveland-Lens manufacturer Luxottica Group SpA will buy Cleveland-based Cole National Corp. in a deal estimated at $401 million, assuming the Italian eyewear designer meets a request from the Federal Trade Commission (FTC). The agency is asking for additional information and documents regarding Luxottica's proposed purchase of Cole.
Related Videos
Related Content
